Enzo Biochem Reports Results for Second Fiscal Quarter
Enzo Biochem, Inc. (NYSE:ENZ), a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, today reported financial results for the three and six months ended January 31, 2010.
Read more on Finanzen.net
‘Smart’ nanoparticles target specific cancer cells
Scientists in the U.S. have created synthesized nanoparticles that can identify, target and kill specific cancer cells while leaving healthy cells alone.
Read more on Sify News